Of all the predicted targets, the zinc finger protein 177 (ZNF177) gene was selected because it has been described as being epigenetically silenced in other tumor types [52,53,54], including gynecological cancers [55,56]. The gene discussed is ZNF177; the disease is female reproductive organ cancer.